Lipid profiles ART naïve (n=71) ART (n=70) P –value  OR (95%CI )
TC mean  (SD) 162.4 (46.1) 195.3 (48.1) 0.001* 17.2-48.6
TC>200 mg/dL, n (%)W 15 (21.1) 32 (45.7) 0.002* 3.1 (1.5- 6.6)
TG mean (SD) 124.7 (60.9) 147.7 (70.3) 0.049* 0.07- 43.6
TG > 150 mg/dL, n (%)W 23 (32.4) 28 (40.0) 0.4 1.4  (0.7- 2.8)
LDL-c, mean (SD) 107.3 (45.3) 113.4 (39.4) 0.4 -6.6-20.8
LDL-c> 130 mg/dL, n (%)W 21 (29.6) 28 (40.0) 0.2 1.6  (0.8-3.2)
HDL-c, mean (SD) 55.2 (24.3) 51.54 (17) 0.3 -2.9-10.7
HDL-c <40 mg/dL, n (%)W 12 (16.9) 16 (22.9) 0.4 1.5; 0.6-3.4
TC/HDL-c ratio ≥ 5, n (%)W 6 (8.5) 19 (27.1) 0.006* 4.0  (1.5-10.8)
TG/HDL-c ratio ≥ 2.4, n (%)W 30 (42.3) 42 (60.0) 0.036* 2.05 (1.05-4.0)
n (%)W= number of case ( percentages),  ART= antiretroviral therapy, SD=standard deviation, OR = odds ratio, *statistically significant difference, TC=Total Cholesterol, HDL-c= High Density Lipoprotein -Cholesterol, LDL-c= Low Density Lipoprotein-Cholesterol, TG = Triglyceride
Table 3: Prevalence of lipid profile derangements and their association with use of ART at TikurAnbesa hospital, Addis Ababa-Ethiopia, 2013.